// App-Quantinova.ai

2151 : Nonalcoholic Steatohepatitis (NASH) Impairs Ventricular Diastolic Distensibility And Function Independent Of Underlying Type 2 Diabetes Or Hypertension

Researchers

Presenter

  • Mohammad Siddiqui

Principal Investigators

  • Oliver Rider

  • Ines Abdesselam

  • Rebecca Collen

  • keri hildick

  • Robert E. Cadrain

  • Joel L. Steinberg

  • Michael O. Idowu

  • Melissa J. Contos

  • Stefan Neubauer

  • Arun J. Sanyal

Medical Centers

  • Virginia Commonwealth University, Mineral, VA

  • Oxford Outcomes, Oxford, United Kingdom

  • Prespectum Diagnostics, Oxford, United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic steatohepatitis

  • Myocardial Dysfunction

  • Fatty Liver Disease

  • Type 2 diabetes mellitus

  • Heart muscle disease

  • Congestive heart failure

  • Hypertension

  • Cirrhosis

  • Diabetes

  • Stroke

  • Nonalcoholic fatty liver disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved